Your browser doesn't support javascript.
loading
Identification of cisplatin sensitizers through high-throughput combinatorial screening.
Sun, Yichen; Jiang, Weiye; Lu, Wenhua; Song, Ming; Liu, Kaiyan; Chen, Ping; Chang, Allison; Ling, Jianhua; Chiao, Paul J; Hu, Yumin; Huang, Peng.
Afiliação
  • Sun Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.
  • Jiang W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.
  • Lu W; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.
  • Song M; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.
  • Liu K; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.
  • Chen P; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.
  • Chang A; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Ling J; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Chiao PJ; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Hu Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.
  • Huang P; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.
Int J Oncol ; 53(3): 1237-1246, 2018 Sep.
Article em En | MEDLINE | ID: mdl-29956742

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios de Seleção de Medicamentos Antitumorais / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Ensaios de Triagem em Larga Escala / Neoplasias Tipo de estudo: Diagnostic_studies / Evaluation_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios de Seleção de Medicamentos Antitumorais / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino / Ensaios de Triagem em Larga Escala / Neoplasias Tipo de estudo: Diagnostic_studies / Evaluation_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article